Novasign Studio is a bioprocess modeling, simulation and decision-support platform that helps pharma, biotech and CDMO teams gain more knowledge from existing process data and make faster, better-justified development decisions.
Studio connects experimental design, data preparation, model building and simulation in one transparent, reusable workflow environment. Users can combine mechanistic knowledge with data-driven methods through hybrid modeling, keeping models explainable while capturing complex process behavior. Teams can explore operating ranges, identify critical parameters, compare scenarios and select the most informative next experiments before committing further laboratory time and material.
The platform supports upstream and downstream applications, including media optimization, fermentation and cell culture, filtration, chromatography, scale-up, technology transfer, process characterization and digital twin development.
For CDMOs, Studio supports faster project delivery, fewer experimental runs, transparent sponsor communication and workflows that can be adapted and reused across client projects. For pharmaceutical and biotechnology companies, it helps preserve process knowledge, increase development efficiency, assess scale-up risks and document decisions for regulatory filings.
Studio provides an intuitive no-code environment for process experts while enabling data scientists to integrate custom code, models and data sources. API-ready integration, collaboration and cloud-based or fully on-premises deployment allow organizations to fit Studio to their infrastructure and data requirements.
Novasign Studio can reduce experimental effort by up to 70%, shorten optimization cycles and turn fragmented data into transparent, transferable process knowledge. Visit the Novasign startup booth at CPHI Milan to discover how model-assisted development can strengthen competitiveness and support more confident process decisions.
